Emergency medics locked out of EHRs; why the Holmes conviction hinged on defrauding investors

Medics are often unable to access a patient's medical history when they arrive on scene, even though it would help them make crucial decisions. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

'A black box': Emergency medics remain locked out of electronic health records By Marion Renault Justin Sullivan/Getty Images Emergency medics are largely locked out of electronic health record systems, which creates problems for both patients and the medics. Read More STAT+: Why the conviction of Elizabeth Holmes hinged on defrauding Theranos investors, not patients By Casey Ross Nic Coury/AP A key takeaway from the conviction of Elizabeth Holmes: The investors behind Theranos proved to be clearer victims than its patients. Read More Opinion: Confessions of a 'human guinea pig': Why I'm resigning from Moderna vaccine trials By Jeremy Menchik Mark Lennihan/AP I volunteered to be in trials of the Moderna vaccine. I wouldn't have if I had known about the company's relentless quest for profits. Read More Sponsor content by STAT Events STAT@JPM: Will 2022 bring biotech renewal? Come explore what's happening in biotech, virtually, with STAT's Adam Feuerstein. On Jan. 11, he'll convene experts and reporters to discuss the need-to-know news from biotech's biggest confab, and ask what it all means for the year ahead. STAT+: Texas is trying to create the next research triangle for biotech. Will it work? By Maddie Bender Business Wire via AP Austin, Dallas, and Houston are combining resources to create a triangle of innovation, hoping to succeed where others have failed. Read More STAT+: FDA's vaccines and biologics chief talks Covid-19, 2022 priorities, and getting back to gene, cell therapy review By Nicholas Florko Jim Lo Scalzo/Pool via AP The FDA's Center for Biologics Evaluation and Research is hoping 2022 is the year it can get back to normal. Read More STAT+: Applied Therapeutics tried to muzzle short sellers — but the truth still came out By Adam Feuerstein The New York drug maker hired a lawyer to find the people shorting its stock and to scare them into silence.  Read More Covid-19 politics force state lawmakers to ponder pharma campaign cash By Rachel Cohrs Cindy Ord/Getty Images for Pfizer/BioNTech Rep. Beth Liston, an Ohio state lawmaker, supports Covid vaccines. But polarized politics led her to refuse contributions from their makers. Read More Opinion: Health tech needs to rebuild trust in the wake of the Theranos verdict By David Stein Kristoffer Tripplaar/AP The health care technology community must learn from — and move past — the Theranos debacle to help patients benefit from new technologies. Read More Tuesday, January 4, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser